Heart failure patients who are vaccinated against COVID-19 have an 82% greater likelihood of living longer than those who are not vaccinated, according to research presented today at Heart Failure 2024, a scientific congress of the European Society of Cardiology (ESC). more
More than one million lives were saved in Europe due to COVID-19 vaccines, says WHO

COVID-19 vaccines saved at least 1.4 million lives in Europe – “irrefutable” proof of the power of these inoculations, the regional head of the World Health Organization ...

Katalin Kariko, Drew Weissman clinch Nobel Prize in medicine for their work in mRNA COVID-19 vaccines

Katalin Kariko and Drew Weissman got the Nobel Prize for Medicine for developing effective mRNA vaccines against COVID-19 since the pandemic started in 2020.

Study finds obesity accelerates loss of COVID-19 vaccination immunity

The protection offered by COVID-19 vaccination declines more rapidly in people with severe obesity than in those with normal weight, scientists at the Universities of Cambridge and Edinbu ...

COVID-19: China ‘making enormous progress’ to get every older adult vaccinated

New York: China is “making enormous progress and effort” to get every older adult vaccinated against COVID-19, the UN health agency said on Friday, while also cautioning that ...

COVID-19 vaccine access in conflict areas remains critical

New York: Although safe and effective COVID-19 vaccinations are available, the pandemic is still far from over, and countries affected by conflict are in danger of being left behind, the ...

WHO warns against blanket boosters, as vaccine inequity persists

New York: Blanket COVID-19 vaccine booster programmes could prolong the pandemic and increase inequity, the Director-General of the World Health Organization (WHO) warned on Wednesday.

UN agency begins COVID vaccine rollout for 7,500 stranded migrants in Yemen

New York: The International Organization for Migration (IOM) has begun a COVID-19 vaccination campaign for migrants stranded in Yemen. The goal is to inoculate around 7,500 people at its ...

Vaccines shown to induce lower levels of neutralising antibodies against Omicron coronavirus variant: Study

London: Researchers from the University of Oxford have analysed the impact of the Omicron COVID-19 variant of concern on one of the immune responses generated by vaccination.

Pfizer COVID-19 vaccine is safe for children aged between 5 to 11, show Clinical trial results

New York: Pfizer Inc and BioNTech SE on Monday announced results from a Phase 2/3 trial showing a favorable safety profile and robust neutralizing antibody responses in children 5 to 11 y ...